PTC Therapeutics Inc., of South Plainfield, N.J., said the sole underwriter of its January public offering of 6.72 million shares partially exercised its option to purchase additional shares, increasing the total offering to about 7.6 million shares. PTC's aggregate net proceeds are expected to total about $224.1 million. RBC Capital Markets acted as the sole book-running manager.